首页> 外文期刊>Talanta: The International Journal of Pure and Applied Analytical Chemistry >DNase I enzyme-aided fluorescence signal amplification based on graphene oxide-DNA aptamer interactions for colorectal cancer exosome detection
【24h】

DNase I enzyme-aided fluorescence signal amplification based on graphene oxide-DNA aptamer interactions for colorectal cancer exosome detection

机译:基于石墨烯氧化物-DNA适体相互作用的直肠癌外科检测的DNase I酶辅助荧光信号扩增

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Exosomes have proved to be an effective cancer biomarker with significant potential, and several cell-specific molecules have been found in colorectal cancer (CRC) exosomes. Nevertheless, it is challenging to use exosomes in clinical lab diagnostics due to their nanoscale and the lack of a convenient and effective detection platform. Here, we developed a DNase I enzyme-aided fluorescence amplification method for CRC exosome detection, based on graphene oxide (GO)-DNA aptamer (CD63 and EpCAM aptamers) interactions. The fluorescence of fluorophore-labeled aptamers quenched by GO, recovered after incubation with samples containing CRC exosomes. The DNase I enzyme digested the single-stranded DNA aptamers on the exosome surface and the exosomes were able to interact with more fluorescent aptamer probes, resulting in an increase of signal amplification. The limit of detection for CRC exosomes is 2.1 x 10(4) particles/mu l. Consequently, a rapid and effective method with high sensitivity was established. The method was verified in 19 clinical blood serum samples to distinguish healthy and CRC patients, showing significant diagnostic power. Moreover, it can be expanded to other kinds of cancer exosomes, in addition to CRC.
机译:Exosomes已被证明是一种有效的癌症生物标志物,具有显着潜力,并且在结肠直肠癌(CRC)外泌体中发现了几种细胞特异性分子。然而,由于纳米级和缺乏方便且有效的检测平台,在临床实验室诊断中使用外来体并缺乏挑战。在这里,我们开发了一种用于CRC外出检测的DNase I酶辅助荧光扩增方法,基于石墨烯氧化物(GO)-DNA适体(CD63和EPCAM适体)相互作用。通过Go淬灭的荧光团标记的适体的荧光,与含有CrC外泌体的样品一起孵育后回收。将DNase I酶消化在外侧表面表面上消化了单链DNA适体,并且外泌体能够与更多荧光的适体探针相互作用,导致信号放大的增加。 CRC外来体的检测极限为2.1×10(4)颗粒/μL。因此,建立了具有高灵敏度的快速有效的方法。该方法在19个临床血清样本中核实,以区分健康和CRC患者,显示出显着的诊断能力。此外,除CRC之外,它还可以扩展到其他种类的癌症外瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号